← Open Payments lookup

ABIGAIL DOYLE: Open Payments

NPI 1164264347 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,723 in 69 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,723

Food & beverage: $1,723
CompanyPaymentsAmount
ABBVIE INC.13$366
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$226
Madrigal Pharmaceuticals7$217
GENZYME CORPORATION7$203
Takeda Pharmaceuticals U.S.A., Inc.6$156
PFIZER INC.7$141
Ardelyx, Inc.5$93
Janssen Biotech, Inc.4$92
QOL Medical, LLC2$57
Braintree Laboratories, Inc.3$54

Products named: RINVOQ, XIFAXAN, REZDIFFRA, DUPIXENT, XELJANZ, ENTYVIO, SKYRIZI, IBSRELA.

Industry payments across MA — which companies pay providers there.